Feng S.,University of South China |
Ling H.,University of South China |
Guo H.,Tumor Hospital of Hunan Province |
Tong L.,University of South China |
And 5 more authors.
Journal of Thoracic Disease | Year: 2014
ERBB2 mutations have been reported to occur in a subset of patients with lung adenocarcinomas or lung squamous cell carcinomas for some ethnicities, but it is unclear for Chinese patients with lung squamous cell carcinomas up to now. We retrospectively evaluated the status of ERBB2 mutations in a large cross-sectional cohort of 212 Chinese patients with non-small cell lung cancer (NSCLC) diagnosed in several hospitals from southern China during a time period of 1.5 years by polymerase chain reaction (PCR)- based direct sequencing and PCR-single strand conformation polymorphism (PCR-SSCP) analysis. ERBB2 mutation was found in 1 of 49 lung adenocarcinomas (2.0%) and none in lung squamous cell carcinomas and lung adenosquamous carcinomas. It implies the occurrence of ERBB2 mutations is infrequent in Chinese patients with NSCLC, especially in lung squamous cell carcinomas. © Pioneer Bioscience Publishing Company.
Deng Y.F.,Xiamen University |
Deng Y.F.,Fujian Medical University |
Zhou D.N.,Xiamen University |
Ye C.S.,Fujian Medical University |
And 2 more authors.
Annals of Otology, Rhinology and Laryngology | Year: 2012
Objectives: We investigated the expression and clinical value of MTA1 and RECK genes in patients with nasopharyngeal carcinoma (NPC). Methods: We examined MTA1 and RECK expression in nasopharyngeal tissue from patients with chronic nasopharyngitis, lymph nodes with metastasis of NPC, and primary NPC tumor tissue by means of in situ hybridization and analyzed their correlation with the clinicopathologic features of NPC. Results: The positive expression of MTA1 in the NPC tissues and metastatic lymph nodes was significantly higher than that in the chronic nasopharyngitis tissues (p < 0.05). The positive expression of RECK in the NPC tissues and metastatic lymph nodes was significantly lower than that in the chronic nasopharyngitis tissues (p < 0.05). The RECK expression level was inversely correlated with the MTA1 expression level in the NPC tissues (p < 0.05). The increased MTA1 and decreased RECK expressions in the NPC tissues had no association with gender, age, T-stage, or clinical stage (p > 0.05). However, they had a positive correlation with cervical lymph node metastasis, tumor recurrence, and 5-year overall survival rate of the patients with NPC (p < 0.05). Moreover, multivariate analysis showed that MTA1 and RECK expressions were independent prognostic factors for survival (p < 0.05). Conclusions: The conversely abnormal expression levels of MTA1 and RECK may be collectively involved in progression of malignancies and may serve as molecular predictors for metastasis, recurrence, and prognosis of NPC. © 2012 Annals Publishing Company. All rights reserved.
PubMed | Sun Yat Sen University, Tumor Hospital of Fujian Province, Central South University, Anhui Medical University and 10 more.
Type: Journal Article | Journal: Oncotarget | Year: 2015
The safety and efficacy of S-1 plus cisplatin in Chinese advanced gastric cancer patients in first line setting is unknown. In this pilot study, patients with advanced gastric or gastro-esophageal junction adenocarcinoma were enrolled and randomly assigned in a 1:1 ratio to receive S-1 plus cisplatin (CS group) or 5-FU plus cisplatin (CF group). The primary endpoint was time to progression (TTP). Secondary end points included overall survival (OS) and safety. This study was registered on ClinicalTrials. Gov, number NCT01198392. A total of 236 patients were enrolled. Median TTP was 5.51 months in CS group compared with 4.62 months in CF group [hazard ratio (HR) 1.028, 95% confidential interval (CI) 0.758-1.394, p = 0.859]. Median OS was 10.00 months and 10.46 months in CS and CF groups (HR 1.046, 95%CI 0.709-1.543, p = 0.820), respectively. The most common adverse events in both groups were anemia, leukopenia, neutropenia, nausea, thrombocytopenia, vomiting, anorexia and diarrhea. We find that S-1 plus cisplatin is an effective and tolerable option for advanced gastric or gastro-esophageal junction adenocarcinoma patients in China.
PubMed | Tumor Hospital of Hunan Province and Sun Yat Sen University
Type: Journal Article | Journal: PloS one | Year: 2015
Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) in the elderly has rarely been reported. This study aimed to explore the clinical characteristics and prognosis of this entity.In situ hybridization (ISH) analysis of Epstein-Barr virus (EBV) and immunohistochemistry was performed in 230 tumor specimens from consecutive de novo DLBCL patients over 50 years old. A matched-case control analysis (1:3) was utilized to compare EBV-positive and EBV-negative DLBCL in the elderly.A total of 16 patients (7.0%) were diagnosed with EBV-positive DLBCL. Of these 16 cases, the median age was 62 years, with a male to female ratio of 11:5. Elderly EBV-positive DLBCL patients had a higher incidence of non-germinal center B-cell (non-GCB) subtypes (87.5%) and high Ki67 (75%) and CD30 expression (93.8%). For EBV-positive patients undergoing initial chemotherapy, 7 of 16 (43.8%) had complete remission, 2 (12.5%) had partial remission, 2 (12.5%) had stable disease, and 5 (31.3%) had progressive disease. The median overall survival was 9 months for the EBV-positive patients. A matched-case control analysis suggested that EBV-positive patients had inferior survival outcomes compared with EBV-negative patients (3-year progression-free survival [PFS]: 25% vs. 76.7%, respectively; 3-year overall survival [OS]: 25% vs. 77.4%, respectively; P<0.001).EBV-positive DLBCL of the elderly is associated with an inferior clinical course and inferior survival outcomes. The role of EBV in this disease and the optimal management of this subgroup warrants further investigation.
Xu X.,Central South University |
Ren H.,Tumor Hospital of Hunan Province |
Zhou B.,Central South University |
Zhao Y.,Creighton University |
And 4 more authors.
Lung Cancer | Year: 2012
Background: Cisplatin toxicity severely obstacles successful chemotherapy in lung cancer patients. Cisplatin uptake is considered as one of the major factors contributing to the side effects of cisplatin. Genetic variances of core genes also affect cisplatin toxicity. It has been identified that CTR1, copper transporter protein 1, plays an essential role in cisplatin uptake. The purpose of this study is to investigate whether CTR1 polymorphism is associated with platinum toxicity in non-small cell lung cancer (NSCLC) patients. Method: 204 incident NSCLC patients from three different institutions were enrolled and followed up. These patients were histologically confirmed with non-small cell lung cancer. All patients have accepted cisplatin-based chemotherapy for at least two cycles. Twenty SNPs of CTR1 were detected in these patients. Result: CTR1 rs10981694 A>C polymorphism is associated with cisplatin induced severe toxicity in NSCLC patients. C-carrier subjects presented poorer tolerance to ototoxicity (p<0.05). The survival times of patients with different rs10981694 genetic polymorphism were not significantly different. Conclusion: NSCLC patients carrying C allele of CTR1 rs10981694 presented more sensitivity to ototoxicity after cisplatin treatment. CTR1 plays an essential role in cisplatin toxicity and could be considered as a predictor for pretreatment evaluation in lung cancer patients. © 2012 Elsevier Ireland Ltd.
Yang J.,Tumor Hospital of Hunan Province |
Fang X.,Central South University
Journal of Central South University (Medical Sciences) | Year: 2012
Objective: To examine the expression of DNMT1, DNMT3a, and DNMT3b in the eutopic and ectopic endometrium in women with endometriosis. Methods: RT-PCR and real-time RT-PCR were used to examine the expression of DNMT1, DNMT3a, and DNMT3b in the eutopic and ectopic endometrium in 20 women with endometriosis and the endometrium in 20 women without endometriosis. Immunofluorescene staining was used to detect the expression of DNMT1 in these tissues. Results: The expression levels of DNMT1, DNMT3a, and DNMT3b were significantly lower in the ectopic endometrium and eutopic endometrium than those of the control endometium (P<0.05). The changes in the ectopic endometium compared with the control endometium were 0.44, 0.12, and 0.27 folds for DNMT1, DNMT3a, and DNMT3b, respectively, and these in the eutopic endometrium were 0.27, 0.13, and 0.15 folds for DNMT1,DNMT3a, and DNMT3b, respectively. The expression level of DNMT1, DNMT3a, and DNMT3b between the ectopic endometrium and eutopic endometrium was not significantly different (P>0.05 ). Immunofluorescence staining that DNMT1 protein level signigicantly decreased in the ectopic endometrium and eutopic endometrium of endometriosis patients. Conclusion: Decreased expression levels of DNMT1, DNMT3a, and DNMT3b in the ectopic endometrium and eutopic endometrium may play a role in patients with abnormal epigenetics which may lead to endometriosis.
Yu M.,Central South University |
Xu X.-J.,Central South University |
Yin J.-Y.,Central South University |
Wu J.,Central South University |
And 7 more authors.
Clinical Pharmacology and Therapeutics | Year: 2010
This study showed that the polymorphisms KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) are associated with a heightened risk of developing type 2 diabetes mellitus (T2DM). We also explored the effects of these polymorphisms on the efficacy of repaglinide therapy in Chinese patients with T2DM. A total of 259 patients with T2DM and 188 healthy controls were genotyped. Forty patients with various genotypes were randomly selected to undergo an 8-week repaglinide treatment regimen. Patients with the G allele of the KCNJ11 Lys23Glu polymorphism showed higher levels of fasting plasma glucose (FPG) and postprandial plasma glucose (PPG) (P >0.05). After repaglinide treatment, patients with the GA or AA genotype showed higher levels of FPG, PPG, and glycated hemoglobin (HbA 1c) compared with patients with the GG genotype (P >0.05). Patients with the C allele of TCF7L2 rs290487(C/T) had higher total cholesterol levels and lower body mass index (BMI) (P> 0.05). In patients with the TT genotype, the drug showed better efficacy with respect to levels of fasting insulin, triglycerides, and low-density lipoprotein cholesterol (LDL-c) than in patients with the CC or CT genotype (P >0.05). The KCNJ11 and TCF7L2 polymorphisms were associated with repaglinide efficacy. © 2009 American Society for clinical Pharmacology and Therapeutics.
Shen H.,Central South University |
Huang J.,Central South University |
Pei H.,Central South University |
Zeng S.,Central South University |
And 4 more authors.
Cancer Science | Year: 2013
The aim of the present study is to profile differentially expressed protein markers between left-sided colon cancer (LSCC) and right-sided colon cancer (RSCC). Fresh tumor tissue samples from LSCC (n = 7) and RSCC (n = 7) groups were analyzed by two-dimensional electrophoresis coupled with MALDI-TOF-MS, followed by Western blotting. In 50 paraffin embedded samples from each group, levels of four differentially expressed proteins (identified by proteomics analysis) were measured by tissue microarray with immunohistochemistry staining to compare the different protein markers between LSCC and RSCC. Sixteen proteins were found to be differentially expressed between LSCC and RSCC. Ten proteins including HSP-60 and PDIA1 were identified to be highly expressed in LSCC (P < 0.01 or P < 0.05), while the expression of six proteins including EEF1D and HSP-27 were higher in RSCC (P < 0.01 or P < 0.05). Virtually all of the indentified proteins were involved in cellular energy metabolism, protein folding/unfolding, and/or oxidative stress. Human colon tumors at various locations have different proteomic biomarkers. Differentially expressed proteins associated with energy metabolism, protein folding/unfolding and oxidative stress contribute to different tumorigenesis, tumor progression, and prognosis between left- and right-sided colon cancer. © 2012 Japanese Cancer Association.
Xia X.-B.,Central South University |
Xia X.-B.,Tumor Hospital of Hunan Province |
Tan C.-L.,Central South University
Journal of Neuroradiology | Year: 2013
Objective: To evaluate the value of magnetic susceptibility-weighted imaging (SWI) for measuring deep cerebral venous diameter. Methods: The diameters of 150 deep cerebral veins were measured by SWI and digital subtraction angiography (DSA) in 50 patients. Results: SWI showed whole cerebral veins as clear soft vessels, but with a crooked hypointense linear structure along the sulcus. Venous vessel diameter as measured by SWI was greater than that by DSA, but values from the two different techniques showed significant linear correlation (r= 0.905). Conclusion: SWI is reliable and suitable for quantitative measurements of deep cerebral veins, and more sensitive for measuring smaller vessels deep within the brain. © 2013 Elsevier Masson SAS.
Peng X.-W.,Central South University |
Peng X.-W.,Tumor Hospital of Hunan Province |
Li W.,Central South University |
Tan G.-L.,Central South University
Tumor | Year: 2011
Objective: To observe whether cisplatin (DDP) can reverse taxol-resistant phenotype of human nasopharyngeal carcinoma cell lines HNE-2/taxol and 5-8F/taxol. Methods: The inhibitory effects of DDP on the proliferation of parental cell lines (HNE-2 and 5-8F) and taxol-resistant cell lines (HNE-2/taxol and 5-8F/taxol) were detected by colony formation assay. The influence of a low dose of DDP on drug resistance index of taxol-resistant nasopharyngeal carcinoma cells was estimated by colony formation assay. The combined effect of taxol with DDP was measured by isobologram and combination index (CI) analyses. The effects of DDP at different concentrations on the apoptotic rates of taxol-resistant cells and their parental cells were detected by flow cytometry. Results: The taxolresistant nasopharyngeal carcinoma cells showed more sensitive to DDP than their parental cells ( P<0.05). A synergistic inhibitory effect on the growth of taxol-resistant cells was observed after treatment with a combination of taxol with DDP, while an additive inhibitory effect on the growth of parental cells was observed after the same treatment. Moreover, a low dose of DDP significantly decreased the drug resistant index of taxol-resistant cells compared to that of their parental cells. The apoptotic rates of taxol-resistant cells were significantly higher than those of their parental cells after exposure to DDP ( P<0.05). Conclusion: DDP can reverse taxol-resistance of human nasopharyngeal carcinoma cell lines. DDP in combination with taxol has a synergistic growth-inhibitory effect on taxol-resistant human nasopharyngeal carcinoma cell lines. Copyright@2009-2010 Tumor All rights reserved.